论文部分内容阅读
目的:比较中晚期肺癌咯血的介入治疗与内科治疗的临床疗效。方法:介入治疗,均采用Seldirtger技术,行选择性支气管动脉造影后用明胶海棉、丝线作栓塞,内科治疗、常规采用止血敏、立止血、垂体后叶素等。采用即刻止血率,随访12个月复发率作为疗效的评价。结果:介入治疗组即刻止血率100％。随访12个月复发率12.5％;内科治疗组即刻止血率15.4％,复发率61.5％。结论:中晚期肺癌咯血介入治疗疗效优于内科治疗,且能为后续原发病灶的治疗创造条件。因此,可将介入治疗作为中晚期肺癌咯血的首选治疗方法。
Objective: To compare the clinical efficacy of interventional therapy and medical treatment of hemoptysis in advanced lung cancer. Methods: Seldirtger technique was used in the interventional treatment. Gelatin sponge and silk thread were used for embolization after selective bronchial artery angiography. The patients were treated with traditional Chinese medicine, including hemostasis, stop bleeding and vasopressin. The rate of immediate hemostasis, follow-up of 12 months recurrence rate as the evaluation of the curative effect. Results: The rate of immediate hemostasis was 100% in the intervention group. Follow-up 12 months recurrence rate of 12.5%; medical treatment group immediate hemostasis rate of 15.4%, the recurrence rate of 61.5%. Conclusion: The treatment of hemoptysis in advanced lung cancer is better than medical therapy in interventional therapy, and can create conditions for the treatment of subsequent primary lesions. Therefore, interventional therapy can be used as the preferred treatment of hemoptysis in patients with advanced lung cancer.